PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia
Clinical trial NCT03156790 · TERMINATED
Trial details
- NCT number
- NCT03156790
- Sponsor
- medac GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2025-11-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.